Direct impact of inactivated HIV-1 virions on B lymphocyte subsets

Molecular Immunology

Volumn 44, Issue 8, 2007, Pages 2124-2134

  Viau, Muriel ^a   Veas, Francisco ^b   Zouali, Moncef ^a  

^a INSERM   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

B cells; HIV 1; Innate immunity; Memory B cells

Indexed keywords

ANTIBODY; GLYCOPROTEIN GP 120; CD5 ANTIGEN; IMMUNOGLOBULIN M;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; GENETIC ENGINEERING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE; VIRION; ANIMAL; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; VIRUS INACTIVATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

ANIMALS; ANTIGENS, CD5; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CLONAL DELETION; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES; VIRION; VIRUS INACTIVATION;

EID: 34250317159     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.07.302     Document Type: Article

References (86)

1. Amadori A., De Rossi A., Faulkner-Valle G.P., and Chieco-Bianchi L. Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects. Clin. Immunol. Immunopathol. 46 (1988) 342-351
2. Ballet J.J., Sulcebe G., Couderc L.J., Danon F., Rabian C., Lathrop M., Clauvel J.P., and Seligmann M. Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy. Clin. Exp. Immunol. 68 (1987) 479-487
3. Beniguel L., Begaud E., Cognasse F., Gabrie P., Mbolidi C.D., Sabido O., Marovich M.A., DeFontaine C., Fresard A., Lucht F., Genin C., and Garraud O. Identification of germinal center B cells in blood from HIV-infected drug-naive individuals in Central Africa. Clin. Dev. Immunol. 11 (2004) 23-27
4. Berberian L., Goodglick L., Kipps T.J., and Braun J. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261 (1993) 1588-1591
5. Berberian L., Shukla J., Jefferis R., and Braun J. Effects of HIV infection on VH3 (D12 idiotope) B cells in vivo. J. Acquir. Immune Defic. Syndr. 7 (1994) 641-646
6. Bernasconi N.L., Traggiai E., and Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 (2002) 2199-2202
7. Bessudo A., Rassenti L., Havlir D., Richman D., Feigal E., and Kipps T.J. Aberrant and unstable expression of immunoglobulin genes in persons infected with human immunodeficiency virus. Blood 92 (1998) 1317-1323
8. Carsetti R., Rosado M.M., and Wardmann H. Peripheral development of B cells in mouse and man. Immunol. Rev. 197 (2004) 179-191
9. Chang Q., Abadi J., Alpert P., and Pirofski L. A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased VH3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected persons. J. Infect. Dis. 181 (2000) 1313-1321
10. Chertova E., Crise B.J., Morcock D.R., Bess Jr. J.W., Henderson L.E., and Lifson J.D. Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins. Curr. Mol. Med. 3 (2003) 265-272
11. Chong Y., Ikematsu H., Kikuchi K., Yamamoto M., Murata M., Nishimura M., Nabeshima S., Kashiwagi S., and Hayashi J. Selective CD27+ (memory) B cell reduction and characteristic B cell alteration in drug-naive and HAART-treated HIV type 1-infected patients. AIDS Res. Hum. Retroviruses 20 (2004) 219-226
12. Conge A.M., Tarte K., Reynes J., Segondy M., Gerfaux J., Zembala M., and Vendrell J.P. Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease. Aids 12 (1998) 1437-1449
13. David D., Goossens D., Desgranges C., Theze J., and Zouali M. Molecular characterization of human monoclonal antibodies specific for several HIV proteins: analysis of the VH3 family expression. Immunol. Lett. 47 (1995) 107-112
14. De Milito A., Morch C., Sonnerborg A., and Chiodi F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. Aids 15 (2001) 957-964
15. Demaison C., David D., Letourneur F., Theze J., Saragosti S., and Zouali M. Analysis of human VH gene repertoire expression in peripheral CD19+ B cells. Immunogenetics 42 (1995) 342-352
16. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., and Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381 (1996) 661-666
17. Dimitrov D.S., Willey R.L., Sato H., Chang L.J., Blumenthal R., and Martin M.A. Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67 (1993) 2182-2190
18. Doepper S., Stoiber H., Kacani L., Sprinzl G., Steindl F., Prodinger W.M., and Dierich M.P. B cell-mediated infection of stimulated and unstimulated autologous T lymphocytes with HIV-1: role of complement. Immunobiology 202 (2000) 293-305
19. Dopper S., Wilflingseder D., Prodinger W.M., Stiegler G., Speth C., Dierich M.P., and Stoiber H. Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures. Eur. J. Immunol. 33 (2003) 2098-2107
20. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., and Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381 (1996) 667-673
21. Emini E.A., Schleif W.A., Nunberg J.H., Conley A.J., Eda Y., Tokiyoshi S., Putney S.D., Matsushita S., Cobb K.E., Jett C.M., et al. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature 355 (1992) 728-730
22. Fitzgerald W., Sylwester A.W., Grivel J.C., Lifson J.D., and Margolis L.B. Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo. J. Virol. 78 (2004) 7061-7068
23. Fondere J.M., Huguet M.F., Yssel H., Baillat V., Reynes J., van de Perre P., and Vendrell J.P. Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy. Aids 17 (2003) 2323-2330
24. Forster R., Schweigard G., Johann S., Emrich T., Kremmer E., Nerl C., and Lipp M. Abnormal expression of the B-cell homing chemokine receptor BLR1 during the progression of acquired immunodeficiency syndrome. Blood 90 (1997) 520-525
25. Gallo M.L., Ivanov V.E., Jakobovits A., and Davis C.G. The human immunoglobulin loci introduced into mice: V (D) and J gene segment usage similar to that of adult humans. Eur. J. Immunol. 30 (2000) 534-540
26. Gary-Gouy H., Harriague J., Bismuth G., Platzer C., Schmitt C., and Dalloul A.H. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 100 (2002) 4537-4543
27. Gatto D., Ruedl C., Odermatt B., and Bachmann M.F. Rapid response of marginal zone B cells to viral particles. J. Immunol. 173 (2004) 4308-4316
28. Goodglick L., Zevit N., Neshat M.S., and Braun J. Mapping the Ig superantigen-binding site of HIV-1 gp120. J. Immunol. 155 (1995) 5151-5159
29. Goodyear C.S., Narita M., and Silverman G.J. In vivo V(L)-targeted activation-induced apoptotic supraclonal deletion by a microbial B cell toxin. J. Immunol. 172 (2004) 2870-2877
30. Green L.L., and Jakobovits A. Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes. J. Exp. Med. 188 (1998) 483-495
31. Herman A., Kappler J.W., Marrack P., and Pullen A.M. Superantigens: mechanism of T-cell stimulation and role in immune responses. Ann. Rev. Immunol. 9 (1991) 745-772
32. Indraccolo S., Mion M., Zamarchi R., Veronesi A., Veronese M.L., Panozzo M., Betterle C., Barelli A., Borri A., Amadori A., et al. B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5-B cell subsets. J. Clin. Immunol. 13 (1993) 381-388
33. Jacobson M.A., Khayam-Bashi H., Martin J.N., Black D., and Ng V. Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function. J. Acquir. Immune Defic. Syndr. 31 (2002) 472-477
34. Jakubik J.J., Saifuddin M., Takefman D.M., and Spear G.T. Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes. J. Virol. 74 (2000) 552-555
35. Juompan L., Lambin P., and Zouali M. Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection. FASEB J. 12 (1998) 1473-1480
36. Karray S., Juompan L., Maroun R., Isenberg D., Silverman G., and Zouali M. Structural basis of the gp120 superantigen binding site on human immunoglobulins. J. Immunol. 161 (1998) 6681-6688
37. Karray S., and Zouali M. Identification of the B cell superantigen-binding site of HIV-1 gp120. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 1356-1360
38. Kraj P., Rao S.P., Glas A.M., Hardy R.R., Milner E.C., and Silberstein L.E. The human heavy chain Ig V region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells. J. Immunol. 158 (1997) 5824-5832
39. Kwong P.D., Wyatt R., Majeed S., Robinson J., Sweet R.W., Sodroski J., and Hendrickson W.A. Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Struct. Fold Des. 8 (2000) 1329-1339
40. Lane H.C., Masur H., Edgar L.C., Whalen G., Rook A.H., and Fauci A.S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309 (1983) 453-458
41. Laurence J.L.J., Hodtsev A.S., and Posnett D.N. Superantigens in infectious diseases, including AIDS. Ann. N. Y. Acad. Sci. 685 (1993) 746-755
42. Levy J.A. The importance of the innate immune system in controlling HIV infection and disease. Trends Immunol. 22 (2001) 312-316
43. Liu Y.J., and Arpin C. Germinal center development. Immunol. Rev. 156 (1997) 111-126
44. Malaspina A., Moir S., Kottilil S., Hallahan C.W., Ehler L.A., Liu S., Planta M.A., Chun T.W., and Fauci A.S. Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function. J. Immunol. 170 (2003) 5965-5972
45. Marone G., Florio G., Petraroli A., Triggiani M., and de Paulis A. Role of human FcepsilonRI+ cells in HIV-1 infection. Immunol. Rev. 179 (2001) 128-138
46. Martin F., Oliver A.M., and Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14 (2001) 617-629
47. Mascola J.R., Lewis M.G., Stiegler G., Harris D., VanCott T.C., Hayes D., Louder M.K., Brown C.R., Sapan C.V., Frankel S.S., Lu Y., Robb M.L., Katinger H., and Birx D.L. Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J. Virol. 73 (1999) 4009-4018
48. Mascola J.R., Stiegler G., VanCott T.C., Katinger H., Carpenter C.B., Hanson C.E., Beary H., Hayes D., Frankel S.S., Birx D.L., and Lewis M.G. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6 (2000) 207-210
49. Mechulam A., Cerutti M., Pugniere M., Misse D., Gajardo J., Roquet F., Robinson J., and Veas F. Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding. J. Mol. Med. 83 (2005) 542-552
50. Miedema F., Petit A.J., Terpstra F.G., Schattenkerk J.K., de Wolf F., Al B.J., Roos M., Lange J.M., Danner S.A., Goudsmit J., et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men HIV affects the immune system before CD4+ T helper cell depletion occurs. J. Clin. Invest. 82 (1988) 1908-1914
51. Moir S., Malaspina A., Li Y., Chun T.W., Lowe T., Adelsberger J., Baseler M., Ehler L.A., Liu S., Davey Jr. R.T., Mican J.A., and Fauci A.S. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J. Exp. Med. 192 (2000) 637-646
52. Moir S., Malaspina A., Ogwaro K.M., Donoghue E.T., Hallahan C.W., Ehler L.A., Liu S., Adelsberger J., Lapointe R., Hwu P., Baseler M., Orenstein J.M., Chun T.W., Mican J.A., and Fauci A.S. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 10362-10367
53. Moir S., Malaspina A., Pickeral O.K., Donoghue E.T., Vasquez J., Miller N.J., Krishnan S.R., Planta M.A., Turney J.F., Justement J.S., Kottilil S., Dybul M., Mican J.M., Kovacs C., Chun T.W., Birse C.E., and Fauci A.S. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J. Exp. Med. 200 (2004) 587-599
54. Moir S., Ogwaro K.M., Malaspina A., Vasquez J., Donoghue E.T., Hallahan C.W., Liu S., Ehler L.A., Planta M.A., Kottilil S., Chun T.W., and Fauci A.S. Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6057-6062
55. Morris L., Binley J.M., Clas B.A., Bonhoeffer S., Astill T.P., Kost R., Hurley A., Cao Y., Markowitz M., Ho D.D., and Moore J.P. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J. Exp. Med. 188 (1998) 233-245
56. Murakami M., Tsubata T., Shinkura R., Nisitani S., Okamoto M., Yoshioka H., Usui T., Miyawaki S., and Honjo T. Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J. Exp. Med. 180 (1994) 111-121
57. Muro-Cacho C.A., Pantaleo G., and Fauci A.S. Analysis of apoptosis in lymph nodes of HIV-infected persons Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154 (1995) 5555-5566
58. Neshat M.N., Goodglick L., Lim K., and Braun J. Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig. Int. Immunol. 12 (2000) 305-312
59. Nishimura Y., Igarashi T., Haigwood N., Sadjadpour R., Plishka R.J., Buckler-White A., Shibata R., and Martin M.A. Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J. Virol. 76 (2002) 2123-2130
60. Nisitani S., Murakami M., Akamizu T., Okino T., Ohmori K., Mori T., Imamura M., and Honjo T. Preferential localization of human CD5+ B cells in the peritoneal cavity. Scand. J. Immunol. 46 (1997) 541-545
61. Notermans D.W., de Jong J.J., Goudsmit J., Bakker M., Roos M.T., Nijholt L., Cremers J., Hellings J.A., Danner S.A., and de Ronde A. Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses. AIDS Res. Hum. Retroviruses 17 (2001) 1003-1008
62. Ohlin M., and Zouali M. The human antibody repertoire to infectious agents: implications for disease pathogenesis. Mol. Immunol. 40 (2003) 1-11
63. Pahwa R., Good R.A., and Pahwa S. Prematurity, hypogammaglobulinemia, and neuropathology with human immunodeficiency virus (HIV) infection. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 3826-3830
64. Pantaleo G., Graziosi C., and Fauci A.S. Virologic and immunologic events in primary HIV infection. Springer Semin. Immunopathol. 18 (1997) 257-266
65. Parren P.W., Marx P.A., Hessell A.J., Luckay A., Harouse J., Cheng-Mayer C., Moore J.P., and Burton D.R. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 75 (2001) 8340-8347
66. Patella V., Florio G., Petraroli A., and Marone G. HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. J. Immunol. 164 (2000) 589-595
67. Piatak Jr. M., Saag M.S., Yang L.C., Clark S.J., Kappes J.C., Luk K.C., Hahn B.H., Shaw G.M., and Lifson J.D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259 (1993) 1749-1754
68. Qiao X., He B., Chiu A., Knowles D.M., Chadburn A., and Cerutti A. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat. Immunol. 7 (2006) 302-310
69. Redgrave B.E., Stone S.F., French M.A., Krueger R., James I.R., and Price P. The effect of combination antiretroviral therapy on CD5 B- cells B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients. HIV Med. 6 (2005) 307-312
70. Richman D.D., Wrin T., Little S.J., and Petropoulos C.J. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 4144-4149
71. Rossio J.L., Esser M.T., Suryanarayana K., Schneider D.K., Bess Jr. J.W., Vasquez G.M., Wiltrout T.A., Chertova E., Grimes M.K., Sattentau Q., Arthur L.O., Henderson L.E., and Lifson J.D. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol. 72 (1998) 7992-8001
72. Samuelsson A., Sonnerborg A., Heuts N., Coster J., and Chiodi F. Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 13 (1997) 1031-1038
73. Sasso E.H., Silverman G.J., and Mannik M. Human IgM molecules that bind staphylococcal protein A contain VHIII H chains. J. Immunol. 142 (1989) 2778-2783
74. Scamurra R.W., Miller D.J., Dahl L., Abrahamsen M., Kapur V., Wahl S.M., Milner E.C., and Janoff E.N. Impact of HIV-1 infection on VH3 gene repertoire of naive human B cells. J. Immunol. 164 (2000) 5482-5491
75. Schmitz J.E., Kuroda M.J., Santra S., Simon M.A., Lifton M.A., Lin W., Khunkhun R., Piatak M., Lifson J.D., Grosschupff G., Gelman R.S., Racz P., Tenner-Racz K., Mansfield K.A., Letvin N.L., Montefiori D.C., and Reimann K.A. Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 77 (2003) 2165-2173
76. Shibata R., Igarashi T., Haigwood N., Buckler-White A., Ogert R., Ross W., Willey R., Cho M.W., and Martin M.A. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 5 (1999) 204-210
77. Shirai A., Cosentino M., Leitman-Klinman S.F., and Klinman D.M. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J. Clin. Invest. 89 (1992) 561-566
78. Taoufik Y., Peguillet I., de Goer M.G., Lambert M., Gubler B., Trylesinski A., Delfraissy J.F., and Lantz O. Effect of highly active antiretroviral therapy on expression of interleukin-10 and interleukin-12 in HIV-infected patients. J. Acquir. Immune Defic. Syndr. 26 (2001) 303-304
79. Veazey R.S., Shattock R.J., Pope M., Kirijan J.C., Jones J., Hu Q., Ketas T., Marx P.A., Klasse P.J., Burton D.R., and Moore J.P. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat. Med. 9 (2003) 343-346
80. Viau M., Longo N.S., Lipsky P.E., Bjorck L., and Zouali M. Specific in vivo deletion of B-cell subpopulations expressing human immunoglobulins by the B-cell superantigen protein L. Infect. Immun. 72 (2004) 3515-3523
81. Viau M., Longo N.S., Lipsky P.E., and Zouali M. Staphylococcal protein a deletes B-1a and marginal zone B lymphocytes expressing human immunoglobulins: an immune evasion mechanism. J. Immunol. 175 (2005) 7719-7727
82. Viau M., and Zouali M. Molecular determinants of the human antibody response to HIV-1: implications for disease control. J. Clin. Immunol. 21 (2001) 410-419
83. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., Komarova N.L., Nowak M.A., Hahn B.H., Kwong P.D., and Shaw G.M. Antibody neutralization and escape by HIV-1. Nature 422 (2003) 307-312
84. White J., Herman A., Pullen A.M., Kubo R., Kappler J.W., and Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56 (1989) 27-35
85. Zouali M. Unravelling antibody genes. Nat. Genet. 7 (1994) 118-120
86. Zouali M. B-cell superantigens: implications for selection of the human antibody repertoire. Immunol. Today 16 (1995) 399-405